Model for End stage Liver Disease (MELD) and Child-Turcotte- Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions

Archives of Iranian Medicine

Volumn 17, Issue 2, 2014, Pages 118-121

  Rahimi Dehkordi, Nasim ^a   Nourijelyani, Keramat ^b   Nasiri Tousi, Mohsen ^c   Ghodssi Ghassemabadi, Robabeh ^b   Azmoudeh Ardalan, Farid ^c   Nedjat, Saharnaz ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CTP; Liver transplantation; MELD; Waiting list

Indexed keywords

ADOLESCENT; ADULT; AGED; ALGORITHMS; AREA UNDER CURVE; ASCITES; BILIRUBIN; COHORT STUDIES; DISEASE PROGRESSION; END STAGE LIVER DISEASE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; WAITING LISTS; YOUNG ADULT;

EID: 84894245073     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis. Gastroenterol Hepatol. 2009; 24: 1547-1553.
2. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophagealvarices. BrJ Surg. 1973; 60: 646-649.
3. Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores--where are we and where should we go? J Hepatol. 2004; 41: 344-350.
4. Robert A, Chazouilleres O. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology. 1996; 24: 1392-1394.
5. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. JHepatol. 2005; 42: S100-S1007.
6. MalinchocM, KamathPS, Gordon FD, Peine CJ, Rank J, Ter Borgs PCJ. A Model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000; 31: 864-871.
7. Freeman RB, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. The new liver allocation system: moving toward evidencebased transplantation policy. Liver Transplant. 2002; 8: 851-858.
8. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Thereneau TM, Kosberg CL, et al. A model to predict survival in patients with endstage liver disease. Hepatology. 2001; 33: 464-470.
9. Wiesner RH, Mc Diarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transplant. 2001; 7: 567-580.
10. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003; 124: 91-96.
11. Cholongitas E, Marelli L, Shusang V, Senzolo M, RollesK, Patch D, et al. A systematic review of the performance of the Model for End-stage Liver Disease (MELD) in the setting of liver transplantation. Liver Transplant. 2006; 12: 1049-1061.
12. Heuman DM, Mihas AA. Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: one more positive answer. Gastroenterology. 2003; 125: 992-993. Author reply 994-995.
13. DeLong ER, DeLong DM, and Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-845.
14. R Development Core Team (2012). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. Available from: URL: http:// www.R-project.org/.
15. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointest Liver dis. 2007; 16: 403-406.
16. Khademolhosseini F, Malekhosseini SA, Salahi H, Nikeghbalian S, Bahadori A, Lankarani KB. Outcome and characteristics of patients on the liver transplant waiting list: Shiraz experience. Middle East J Digest Dis. 2009; 11: 63-67.
17. Saberifiroozi M, Serati A, Malekhosseini SA, Salahi H, Bahador Ali, Lankarani KB. Analysis of patients listed for liver transplantation in Shiraz, Iran. Indian J Gastroenterol. 2006; 25: 11-13.
18. Murray KF, Carithers RL. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology. 2005; 41: 1-26.
19. Fink MA, Berry SR, Gow PJ, Angus PW, Wang BZ, Muralidharan V, et al. Risk factors for liver transplantation waiting list mortality. J Gastroenterol Hepatol. 2007; 22: 119-124.
20. Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, et al. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. BMC Gastroenterol. 2009; 9: 72.
21. Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, et al. Evaluation of the increase in model for end-stage liver disease (DMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol. 2005; 42: 826-832.
22. Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, et al. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the Mode for End-stage Liver Disease for outcome prediction in patients with cirrhosis. Liver Transplant. 2006; 12: 65-71.